grant

Distress Tolerance and Smoking Cessation

Organization WAKE FOREST UNIVERSITY HEALTH SCIENCESLocation WINSTON-SALEM, UNITED STATESPosted 6 Nov 2021Deadline 31 May 2026
NIHUS FederalResearch GrantFY2023AbstinenceAddressAffectAffectiveAndroid AppAndroid ApplicationAnteriorArkansasAuditoryAuditory CortexAuditory areaAwarenessBehaviorBehavior Conditioning TherapyBehavior ModificationBehavior TherapyBehavior TreatmentBehavioralBehavioral Conditioning TherapyBehavioral ModificationBehavioral TherapyBehavioral TreatmentBrainBrain Nervous SystemCancer CauseCancer EtiologyCancersCell Phone ApplicationCell phone AppCellular Phone AppCellular Phone ApplicationCentral LobeCessation of lifeChemical DependenceChronicCigaretteCognitiveConditioning TherapyCounselingDataDeathDevelopmentDiseaseDisorderDistressDrug AddictionDrug DependenceDrug DependencyDrug TherapyDrug usageEcological momentary assessmentEncephalonEventFunctional MRIFunctional Magnetic Resonance ImagingGoalsIndividualIndividual DifferencesInsulaInsula of ReilInterventionIntervention StrategiesIsland of ReilKnowledgeMalignant NeoplasmsMalignant TumorMeasuresMedical Care CostsMiddle Frontal GyrusMiddle frontal gyrus structureMonitorMoodsNicotine Replacement TherapyNicotine WithdrawalOutcomePatient Self-ReportPharmacotherapyPlayProductivityRelapseResearchRoleSelf-ReportServicesSmart Phone AppSmart Phone ApplicationSmartphone AppSmokerSmokingStandardizationStressTechniquesTestingTherapeutic InterventionTimeTobacco ConsumptionTobacco DependenceTobacco smokingTobacco smoking behaviorTobacco useattributable deathattributable mortalityauditory feedbackbehavior interventionbehavior responsebehavioral interventionbehavioral responsecease smokingcell phone based appcigarette cravingcigarette smokingcigarette usecognitive controlcopingcostcravingdevelopmentaldistress tolerancedrug relapsedrug treatmentdrug useexperiencefMRIiOS appiOS applicationiPhone AppiPhone Applicationimprovedinterestintervention therapyinterventional strategymalignancymedical costsmobile phone appneoplasm/cancerneuralneural controlneural imagingneural mechanismneural regulationneuro-imagingneurofeedbackneuroimagingneurological imagingneuromechanismneuromodulationneuromodulatoryneuroregulationnew drug targetnew drug treatmentsnew druggable targetnew drugsnew pharmacological therapeuticnew pharmacotherapy targetnew therapeutic targetnew therapeuticsnew therapynew therapy targetnext generation therapeuticsnicotine replacementnovel drug targetnovel drug treatmentsnovel druggable targetnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel pharmacotherapy targetnovel therapeutic targetnovel therapeuticsnovel therapynovel therapy targetpersonalized health interventionpersonalized interventionprecision interventionspublic health relevancequit smokingsensory cortexsmartphone applicationsmartphone based appsmartphone based applicationsmoking cessationsmoking interventionsocial rolestop smokingsuccesstargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttobacco addictiontobacco dependenttobacco product use
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

ABSTRACT
Tobacco addiction is a costly and often fatal problem. Even with counseling and nicotine replacement therapy,

most smokers relapse following a quit attempt. For many smokers, cigarette smoking is provoked by affective

distress. The ability to cope with this distress and remain abstinent may depend on one's level of distress

tolerance, which is the ability to persist in a goal-directed activity while experiencing physical or affective

discomfort. However, a gap in knowledge exists regarding the neural mechanisms that underlie distress

tolerance. Identifying these neural mechanisms and understanding individual differences in distress tolerance

holds promise for the development of new therapies and the improvement of cessation success through

personalized interventions.

Past research has shown that cigarette cravings and other forms of affective distress activate the insula,

which may be the neural hub that connects the awareness of affective distress to cognitive control regions that

determine the subsequent behavioral response (e.g., smoking a cigarette to relieve cravings). However, there

is a significant gap in knowledge concerning whether insula connectivity underlies real-world distress tolerance

behavior in the service of smoking cessation. Lab-based measures of distress tolerance provide standardized

comparisons across individuals and could be used to identify smokers who would most benefit from

interventions. A complementary approach, ecological momentary assessment, can capture temporal

relationships among affective distress, craving, and smoking as they occur in smoker's daily lives, in real time.

The goal of this research is to test the predictive validity of lab-based measures of distress tolerance against

the real-world stress/smoking relationship, and to identify neural differences within smokers that relate to

distress tolerance and could predict quit outcomes (i.e., relapsed vs nonrelapsed).

To address this gap in knowledge, we will investigate three aims: Aim 1) Associate lab measures of

distress tolerance to insula connectivity. Aim 2) Relate lab measures of distress tolerance with real-world

stress and smoking using ecological momentary assessment. Aim 3) Explore how insula connectivity relates to

real-world stress and smoking. By providing clear evidence of how distress tolerance, brain connectivity, and

daily stress relate to quit outcomes, this study will greatly increase our understanding of why some smokers

succeed in quitting while others relapse. This research will be generalizable to other drug addictions and

psychiatric conditions that are exacerbated by physical or affective distress. Successful completion of this

study will inform the development of personalized smoking interventions, as well as identify neural

mechanisms that can be targeted by novel therapeutic techniques.

Grant Number: 5R01DA048948-06
NIH Institute/Center: NIH

Principal Investigator: Merideth Addicott

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →